---
figid: PMC11641610__ijms-25-12550-g003
figtitle: Key signaling pathways involved in T cell senescence within the tumor microenvironment
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11641610
filename: ijms-25-12550-g003.jpg
figlink: /pmc/articles/PMC11641610/figure/F3/
number: F3
caption: 'Key signaling pathways involved in T cell senescence within the tumor microenvironment.
  In the immunosuppressive microenvironment formed by tumor cells, the MAPK signaling
  pathway of T cells is persistently activated by the continuous stimulation of tumor
  antigens and metabolic competition. Glucose deprivation results in the phosphorylation
  of P38, resulting in telomere shortening, DNA damage, and cell cycle arrest. Additionally,
  TCR signal transduction in senescent T cells is downregulated, leading to autophagy
  inactivation and further exacerbating mitochondrial dysfunction. Treg: regulatory
  T cell, IFN-γ: interferon-gamma, cAMP: cyclic adenosine monophosphate, ILT4: immunoglobulin-like
  transcript 4, HLA-G: Human leukocyte antigen-G, PKA: phosphorylase kinase A, CREB:
  cAMP response element-binding protein, ATM: ataxia-telangiectasia mutated, AMPK:
  adenosine 5′monophosphate-activated protein kinase, TERT: telomerase reverse transcriptase,
  ERK: extracellular signal-regulated protein kinase, STAT: signal transducer and
  activator of transcription, LCK: lymphocyte-specific protein tyrosine kinase, ZAP70:
  zeta-chain-associated protein kinase 70, ROS: reactive oxygen species, SASP: senescence-associated
  secretory phenotype, TCR: T cell receptor, AKT: protein kinase B, PI3K: phosphatidylinositide
  3-kinase, mTOR: mammalian target of rapamycin, NKG2D: natural killer group 2 member
  D'
papertitle: 'Senescent T Cells: The Silent Culprit in Acute Myeloid Leukemia Progression?'
reftext: Xiaolan Zhang, et al. Int J Mol Sci. 2024 Dec;25(23).
year: '2024'
doi: 10.3390/ijms252312550
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: Multidisciplinary Digital Publishing Institute  (MDPI)
keywords: T cell senescence | acute myeloid leukemia (AML) | tumor microenvironment
  (TME) | therapeutic intervention
automl_pathway: 0.9553704
figid_alias: PMC11641610__F3
figtype: Figure
redirect_from: /figures/PMC11641610__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11641610__ijms-25-12550-g003.html
  '@type': Dataset
  description: 'Key signaling pathways involved in T cell senescence within the tumor
    microenvironment. In the immunosuppressive microenvironment formed by tumor cells,
    the MAPK signaling pathway of T cells is persistently activated by the continuous
    stimulation of tumor antigens and metabolic competition. Glucose deprivation results
    in the phosphorylation of P38, resulting in telomere shortening, DNA damage, and
    cell cycle arrest. Additionally, TCR signal transduction in senescent T cells
    is downregulated, leading to autophagy inactivation and further exacerbating mitochondrial
    dysfunction. Treg: regulatory T cell, IFN-γ: interferon-gamma, cAMP: cyclic adenosine
    monophosphate, ILT4: immunoglobulin-like transcript 4, HLA-G: Human leukocyte
    antigen-G, PKA: phosphorylase kinase A, CREB: cAMP response element-binding protein,
    ATM: ataxia-telangiectasia mutated, AMPK: adenosine 5′monophosphate-activated
    protein kinase, TERT: telomerase reverse transcriptase, ERK: extracellular signal-regulated
    protein kinase, STAT: signal transducer and activator of transcription, LCK: lymphocyte-specific
    protein tyrosine kinase, ZAP70: zeta-chain-associated protein kinase 70, ROS:
    reactive oxygen species, SASP: senescence-associated secretory phenotype, TCR:
    T cell receptor, AKT: protein kinase B, PI3K: phosphatidylinositide 3-kinase,
    mTOR: mammalian target of rapamycin, NKG2D: natural killer group 2 member D'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - LILRB2
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - ASPRV1
  - TRBV20OR9-2
  - TRA
  - TRB
  - TRD
  - TRG
  - HLA-G
  - KLRK1
  - ZAP70
  - ZC3HAV1
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - TERT
  - ATM
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - MAPK3
  - glucose
  - CAMP
  - ROS
---
